Stonepine Capital Management’s ADMA Biologics ADMA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.67M	Hold	740,000	–	–	5.86%	7
2025 Q4	$13.5M	Buy	740,000 +1,000	+0.1%	+$16.9K	10.68%	2
2025 Q3	$10.8M	Sell	739,000 -11,000	-1%	-$189K	8.81%	2
2025 Q2	$13.7M	Sell	750,000 -60,000	-7%	-$1.22M	13.45%	1
2025 Q1	$24.3K	Sell	810,000 -431,032	-35%	-$7.45M	0.02%	62
2024 Q4	$21.3M	Sell	1,241,032 -628,968	-34%	-$11.8M	17.18%	1
2024 Q3	$37.4M	Hold	1,870,000	–	–	23.62%	1
2024 Q2	$20.9M	Sell	1,870,000 -1,556,882	-45%	-$13.1M	19.07%	1
2024 Q1	$22.6M	Sell	3,426,882 -5,795,735	-63%	-$31.7M	17.94%	2
2023 Q4	$41.7M	Buy	9,222,617 +118,342	+1%	+$438K	18.03%	2
2023 Q3	$32.6M	Buy	9,104,275 +310,954	+4%	+$1.2M	10.83%	4
2023 Q2	$32.4M	Buy	8,793,321 +1,131,631	+15%	+$4.19M	11.7%	3
2023 Q1	$25.4M	Buy	7,661,690 +721,690	+10%	+$2.49M	8.51%	4
2022 Q4	$26.9M	Buy	6,940,000 +1,940,000	+39%	+$5.98M	11.33%	4
2022 Q3	$12.2M	Sell	5,000,000 -2,000,000	-29%	-$4.8M	5.46%	6
2022 Q2	$13.9M	Sell	7,000,000 -131,808	-2%	-$259K	6.45%	4
2022 Q1	$13.1M	Sell	7,131,808 -2,779,769	-28%	-$4.34M	5.41%	6
2021 Q4	$14M	Buy	+9,911,577	New	+$13M	6.41%	4
2018 Q3	–	Sell	-831,731	Closed	-$3.75M	–	33
2018 Q2	$3.75M	Buy	+831,731	New	+$4.15M	2.28%	15
2018 Q1	–	Sell	-67,647	Closed	-$217K	–	31
2017 Q4	$217K	Buy	+67,647	New	+$189K	0.13%	26